We collected both tumour and matched normal non-tumorigenic tissue (i.e., background), isolated CD45+ immune cells (Supplementary Fig. 1A) as well as tumour and other non-immune populations (using CD235a column to deplete erythroid cells), and performed scRNA-seq. This evidence concerns the gene GYPA and neoplasm.